Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GK01 Cell Injection in Advanced Lung Cancer
NCT07673419Phase 1Not yet recruiting
- Sponsor
- Beijing Geek Gene Technology
- Start
- Jul 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of GK01 cell injection in lung cancer, sponsored by Beijing Geek Gene Technology. Primary endpoint: Safety and Tolerability at 2 years. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
GK01 cell injection
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT07673419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07673419.